Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Hanover Media Strategy Limited naming Micheál Martin .
Filed returns
15
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2025 | Hanover Media Strategy Limited | Transport | Correspondence regarding the Taxi Supply Shortage (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2024 | Hanover Media Strategy Limited | Children and Youth Affairs | Open letter on proposed sector reforms (Public policy or programme) | 15 | On lobbying.ie |
| May–Aug 2024 | Hanover Media Strategy Limited | Economic Development and Industry | BiopharmaChem Ireland's Budget Submission 2025: sharpening the competitive edge and global leadership of our industry. (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2021 | Hanover Media Strategy Limited | Health | Update on AstraZeneca COVID-19 vaccine and therapies (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Health | Update on COVID-19 Vaccine AstraZeneca (Public policy or programme) | 8 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Health | Update on COVID-19 Vaccine AstraZeneca (Public policy or programme) | 15 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Transport | Cost of Motor Insurance Policies in Ireland (Public policy or programme) | 85 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Health | Briefed select parliamentarians on potential Covid-19 vaccine (Public policy or programme) | 22 | On lobbying.ie |
| May–Aug 2020 | Hanover Media Strategy Limited | Health | Update on potential COVID-19 Vaccine (Matters involving public funds) | 4 | On lobbying.ie |
| Sep–Dec 2019 | Hanover Media Strategy Limited | Health | The reimbursement process and pathway affecting AstraZeneca medicines & engage government on healthcare innovation (Matters involving public funds) | 7 | On lobbying.ie |
| Jan–Apr 2018 | Hanover Media Strategy Limited | Health | Reimbursement of Vimizim for Morquio A Syndrome (Matters involving public funds) | 12 | On lobbying.ie |
| Sep–Dec 2017 | Hanover Media Strategy Limited | Health | Reimbursement of Vimizim for Morquio A Syndome (Matters involving public funds) | 16 | On lobbying.ie |
| Sep–Dec 2017 | Hanover Media Strategy Limited | Health | Reimbursement of Translarna for nonsense mutation Duchenne Muscular Dystrophy (Public policy or programme) | 16 | On lobbying.ie |
| May–Aug 2017 | Hanover Media Strategy Limited | Health | Reimbursement of Translarna for nonsense mutation Duchenne Muscular Dystrophy (Matters involving public funds) | 18 | On lobbying.ie |
| Jan–Apr 2017 | Hanover Media Strategy Limited | Health | Reimbursement of Translarna for nonsense mutation Duchenne Muscular Dystrophy (Matters involving public funds) | 19 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 11 | 73.3% | |
| Transport | 2 | 13.3% | |
| Children and Youth Affairs | 1 | 6.7% | |
| Economic Development and Industry | 1 | 6.7% |